StonvexLoading…
StonvexStonvexStonvexCore line items from HL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $411.43M | $1.42B | $974.91M | $565.37M |
Operating Income | $223.11M | $514.79M | $294.76M | $146.11M |
Net Income | $-19.03M | $321.71M | $187.30M | $86.58M |
EPS (Diluted) | $-0.03 | $0.49 | $0.29 | $0.14 |
Total Assets | $3.38B | $3.56B | $3.22B | $3.31B |
Total Liabilities | $805.48M | $969.00M | $772.20M | $999.32M |
Cash & Equivalents | $587.55M | $241.56M | $133.91M | $296.56M |
Free Cash Flow OCF − CapEx | $154.98M | $310.25M | $175.54M | $85.40M |
Shares Outstanding | 675.15M | 655.77M | 649.53M | 636.99M |